Literature DB >> 7521787

Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.

K Onda1, R L Davis, M Shibuya, C B Wilson, T Hoshino.   

Abstract

BACKGROUND: Recently, it has been shown that heating paraffin embedded tumor sections in a microwave oven can reactivate an epitope of Ki-67 protein that is recognized by the monoclonal antibody MIB-1. With this technique, a close correlation was shown between the bromodeoxyuridine labeling index (BUdR LI) and the MIB-1 proliferating cell index (PCI) in corresponding regions of glioblastomas.
METHODS: The reliability of the MIB-1 PCI as a marker of proliferation was evaluated in 90 cerebral gliomas. The MIB-1 immunostaining of ethanol-fixed, paraffin embedded sections of 23 moderately anaplastic astrocytomas, 22 highly anaplastic astrocytomas, 30 glioblastomas, and 15 mixed malignant gliomas was compared with the BUdR LI and, in some cases, the Ki-67 PCI.
RESULTS: MIB-1 positive cells were detected easily in the majority of the cases, and the MIB-1 immunostaining was often superior to that of Ki-67 in individual tumors. The MIB-1 PCI was significantly higher than the Ki-67 PCI and the BUdR LI. Linear-regression analysis showed significant correlations among the three indices. The MIB-1 PCI was correlated with the BUdR LI in each group of the astrocytic tumors and mixed malignant gliomas; the MIB-1 PCI was approximately 2.4-2.8 times higher than the BUdR LI.
CONCLUSIONS: The close correlation between the MIB-1 PCI and the in vivo BUdR LI in serial sections of glioma subtypes suggests that MIB-1 immunostaining is a useful technique for analyzing the proliferative potential of individual gliomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521787     DOI: 10.1002/1097-0142(19941001)74:7<1921::aid-cncr2820740716>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Cell proliferation in the post-surgical stomach, dietary salt, and the effect of H pylori eradication.

Authors:  P Willis; D A Lynch; R Prescott; S Lamonby
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions.

Authors:  J Sikora; G Dworacki; J Zeromski
Journal:  Lung       Date:  1996       Impact factor: 2.584

3.  Proliferative activity and prognosis of low-grade astrocytomas.

Authors:  D Schiffer; P Cavalla; A Chiò; P Richiardi; M T Giordana
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

4.  Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro.

Authors:  S J Kim; M S Kim; J W Lee; C H Lee; H Yoo; S H Shin; M J Park; S H Lee
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-05       Impact factor: 4.553

5.  Proliferation markers in gliomas: a comparison of BUDR, KI-67, and MIB-1.

Authors:  R L Davis; K Onda; M Shubuya; K Lamborn; T Hoshino
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

6.  Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.

Authors:  J Haapasalo; A Mennander; P Helen; H Haapasalo; J Isola
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

7.  Local interstitial chemotherapy with sustained release bucladesine in de novo glioblastoma multiforme: a preliminary study.

Authors:  Tayfun Dalbasti; Nezih Oktar; Sedat Cagli; Nurcan Ozdamar
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

8.  (99m)Tc-Tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index.

Authors:  Andreas D Fotopoulos; George A Alexiou; Ann Goussia; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Spyridon Voulgaris; Spyridon Tsiouris
Journal:  J Neurooncol       Date:  2008-05-06       Impact factor: 4.130

9.  Comparison of bromodeoxyuridine uptake and MIB 1 immunoreactivity in medulloblastomas determined with single and double immunohistochemical staining methods.

Authors:  K Onda; R L Davis; M S Edwards
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

10.  Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas.

Authors:  Remy Guillevin; Carole Menuel; Hugues Duffau; Michel Kujas; Laurent Capelle; Agnès Aubert; Sophie Taillibert; Ahmed Idbaih; Joan Pallud; Giovanni Demarco; Robert Costalat; Khê Hoang-Xuan; Jacques Chiras; Jean-Noel Vallée
Journal:  J Neurooncol       Date:  2007-12-28       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.